Cyclophosphamide

9 clinical trials · Condition

Record	Firm	Date
MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN (NCT05495893)	Second Xiangya Hospital of Central South University	2022-07-25
Early Identification and Evaluation of Cyclophosphamide Cardiotoxicity (NCT05150080)	Kai Mu	2021-07-10
Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM (NCT04489420)	Celularity Incorporated	2020-10-01
Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis (NCT04464434)	UMC Utrecht	2020-09-17
Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) (NCT03373019)	Fudan University	2017-12-21
Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma (NCT02027220)	Second Affiliated Hospital of Soochow University	2013-12-01
Paclitaxol Every 2 Week Versus Paclitaxol Every 1 Week in the Adjuvant Treatment of Breast Cancer (NCT01848197)	Taizhou Hospital	2013-05-01
Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394) (NCT00590785)	National Cancer Institute (NCI)	1996-08-13

Every clearance here is in the API, with alerts when new ones post.